Perspective: The potential role of essential amino acids and the mechanistic target of rapamycin complex 1 (mTORC1) pathway in the pathogenesis of child stunting

Advances in Nutrition

Volumn 7, Issue 5, 2016, Pages 853-865

  Semba, Richard D ^a   Trehan, Indi ^b   Gonzalez Freire, Marta ^c   Kraemer, Klaus ^d,e   Moaddel, Ruin ^c   Ordiz, M Isabel ^b   Ferrucci, Luigi ^c   Manary, Mark J ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d Sight and Life   (Sweden)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Amino acids; Children; Diet; Food; Growth; MTORC1; Proteins; Stunting

Indexed keywords

ESSENTIAL AMINO ACID; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; PROTEIN INTAKE; TARGET OF RAPAMYCIN KINASE;

ADMINISTRATION AND DOSAGE; BLOOD; BODY HEIGHT; CHILD; CHILD NUTRITION; COMPLICATION; DEFICIENCY; DIET; GROWTH DISORDERS; HUMAN; MALNUTRITION; METABOLISM; PROTEIN INTAKE;

AMINO ACIDS, ESSENTIAL; BODY HEIGHT; CHILD; CHILD NUTRITIONAL PHYSIOLOGICAL PHENOMENA; DIET; DIETARY PROTEINS; GROWTH DISORDERS; HUMANS; MALNUTRITION; MULTIPROTEIN COMPLEXES; TOR SERINE-THREONINE KINASES;

EID: 84992735540     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.116.013276     Document Type: Article

References (173)

1. UNICEF/WHO/World Bank Group. Levels and trends in child malnutrition: key findings of the 2015 edition [cited 2016 Jan 7]. Available from: http://www.who.int/nutgrowthdb/jme_brochure2015.pdf?ua=1.
2. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B; International Child Development Steering Group. Developmental potential in the first 5 years for children in developing countries. Lancet 2007;369:60-70.
3. Victora CG, Adair L, Fall C, Hallal PC, Martorell R, Richter L, Sachdev HS; Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 2008;371:340-57.
4. Olofin I, McDonald CM, Ezzati M, Flaxman S, Black RE, Fawzi WW, Caulfield LE, Danaei G. Nutrition Impact Model Study (anthropometry cohort pooling). Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: a pooled analysis of ten prospective studies. PLoS One 2013;8:e64636.
5. Hoddinott J, Behrman JR, Maluccio JA, Melgar P, Quisumbing AR, Ramirez-Zea M, Stein AD, Yount KM, Martorell R. Adult consequences of growth failure in early childhood. Am J Clin Nutr 2013; 98:1170-8.
6. Sudfeld CR, McCoy DC, Danaei G, Fink G, Ezzati M, Andrews KG, Fawzi WW. Linear growth and child development in low-and middleincome countries: a meta-analysis. Pediatrics 2015;135:e1266-75.
7. de Onis M, Dewey KG, Borghi E, Onyango AW, Blössner M, Daelmans B, Piwoz E, Branca F. The World Health Organization's global target for reducing childhood stunting by 2025: rationale and proposed actions. Matern Child Nutr 2013;9(Suppl 2):6-26.
8. Murray CJ. Shifting to Sustainable Development Goals-implications for global health. N Engl J Med 2015;373:1390-3.
9. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R, et al; Maternal and Child Nutrition Study Group. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013;382:427-51.
10. McLaren DS. The great protein fiasco. Lancet 1974;2:93-6.
11. Waterlow JC, Payne PR. The protein gap. Nature 1975;258:113-7.
12. Maberly GF, Trowbridge FL, Yip R, Sullivan KM, West CE. Programs against micronutrient malnutrition: ending hidden hunger. Annu Rev Public Health 1994;15:277-301.
13. Semba RD. The vitamin A story: lifting the shadow of death. World Rev Nutr Diet 2012;104:i-xv.
14. Bhutta ZA, Salam RA, Das JK. Meeting the challenges of micronutrient malnutrition in the developing world. Br Med Bull 2013;106:7-17.
15. UNICEF. The UNICEF strategic plan, 2014-2017 [cited 2016 Feb 12]. Available from: http://www.unicef.org/strategicplan/.
16. World Health Organization. Micronutrients, 2010-2011. Geneva (Switzerland): World Health Organization. 2011. Document No.: WHO/NMH/NHD/EPG/12.1.
17. Ramakrishnan U, Nguyen P, Martorell R. Effects of micronutrients on growth of children under 5 y of age: meta-analyses of single and multiple nutrient interventions. Am J Clin Nutr 2009;89:191-203.
18. Mayo-Wilson E, Junior JA, Imdad A, Dean S, Chan XH, Chan ES, Jaswal A, Bhutta ZA. Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age. Cochrane Database Syst Rev 2014;5:CD009384.
19. Stammers AL, Lowe NM, Medina MW, Patel S, Dykes F, Pérez-Rodrigo C, Serra-Majam L, Nissensohn M, Moran VH. The relationship between zinc intake and growth in children aged 1-8 years: a systematic review and meta-analysis. Eur J Clin Nutr 2015;69:147-53.
20. Ashorn P, Alho L, Ashorn U, Cheung YB, Dewey KG, Gondwe A, Harjunmaa U, Lartey A, Phiri N, Phiri TE, et al. Supplementation of maternal diets during pregnancy and for 6 months postpartum and infant diets thereafter with small-quantity lipid-based nutrient supplements does not promote child growth by 18 months of age in rural Malawi: a randomized controlled trial. J Nutr 2015;145:1345-53.
21. van der Merwe LF, Moore SE, Fulford AJ, Halliday KE, Drammeh S, Young S, Prentice AM. Long-chain PUFA supplementation in rural African infants: a randomized controlled trial of effects on gut integrity, growth, and cognitive development. Am J Clin Nutr 2013;97:45-57.
22. Ghosh S, Suri D, Uauy R. Assessment of protein adequacy in developing countries: quality matters. Br J Nutr 2012;108(Suppl 2):S77-87.
23. Semba RD, Shardell M, Sakr Ashour FA, Moaddel R, Trehan I, Maleta KM, Ordiz MI, Kraemer K, KhadeerMA, Ferrucci L, et al. Child stunting is associated with low circulating essential amino acids. EBioMedicine 2016;6:246-52.
24. Nuss ET, Tanumihardjo SA. Quality protein maize for Africa: closing the protein inadequacy gap in vulnerable populations. Adv Nutr 2011; 2:217-24.
25. van Dam TJ, Zwartkruis FJ, Bos JL, Snel B. Evolution of the TOR pathway. J Mol Evol 2011;73:209-20.
26. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012;149:274-93.
27. Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991;253:905-9.
28. Vézina C, Kudelski A, Sehgal SN. Rapamycin (AY-22, 989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 1975;28:721-6.
29. Aylett CHS, Sauer E, Imseng S, Boehringer D, Hall MN, Ban N, Maier T. Architecture of human mTOR complex 1. Science 2016;351:48-52.
30. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010;141:290-303.
31. Demetriades C, Doumpas N, Teleman AA. Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell 2014;156:786-99.
32. Bar-Peled L, Schweitzer LD, Zoncu R, Sabatini DM. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 2012;150:1196-208.
33. Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 2011;334:678-83.
34. Tsun ZY, Bar-Peled L, Chantranupong L, Zoncu R, Wang T, Kim C, Spooner E, Sabatini DM. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol Cell 2013;52:495-505.
35. Bar-Peled L, Chantranupong L, Cherniack AD, Chen WW, Ottina KA, Grabiner BC, Spear ED, Carter SL, Meyerson M, Sabatini DM. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 2013;340:1100-6.
36. Jewell JL, Russell RC, Guan KL. Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 2013;14:133-9.
37. Taylor PM. Role of amino acid transporters in amino acid sensing. Am J Clin Nutr 2014;99(Suppl):223S-30S.
38. Shimobayashi M, Hall MN. Multiple amino acid sensing inputs to mTORC1. Cell Res 2016;26:7-20.
39. Saxton RA, Knockenhauer KE, Wolfson RL, Chantranupong L, Pacold ME, Wang T, Schwartz TU, Sabatini DM. Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science 2016;351:53-8.
40. Wang S, Tsun ZY, Wolfson RL, Shen K, Wyant GA, Plovanich ME, Yuan ED, Jones TD, Chantranupong L, Comb W, et al. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 2015;347:188-94.
41. Jewell JL, Kim YC, Russell RC, Yu FX, Park HW, Plouffe SW, Tagliabracci VS, Guan KL. Differential regulation of mTORC1 by leucine and glutamine. Science 2015;347:194-8.
42. Wolfson RL, Chantranupong L, Saxton RA, Shen K, Scaria SM, Cantor JR, Sabatini DM. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 2016;351:43-8.
43. Durán RV, Oppliger W, Robitaille AM, Heiserich L, Skendaj R, Gottlieb E, Hall MN.Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 2012;47:349-58.
44. Kim SG, Hoffman GR, Poulogiannis G, Buel GR, Jang YJ, Lee KW, Kim BY, Erikson RL, Cantley LC, Choo AY, et al. Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex. Mol Cell 2013;49:172-85.
45. Chantranupong L, Scaria SM, Saxton RA, Gygi MP, Shen K, Wyant GA, Wang T, Harper JW, Gygi SP, Sabatini DM. The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell 2016;165:153-64.
46. Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 1998;273: 14484-94.
47. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001;294:1942-5.
48. Dibble CC, Cantley LC. Regulation of mTORC1 by PI3K signaling. Trends Cell Biol 2015;25:545-55.
49. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. Tuberous sclerosis complex-1 and-2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 2002;99:13571-6.
50. DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008;22:239-51.
51. Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006;126:955-68.
52. Budanov AV, Karin M. p53 Target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008;134:451-60.
53. Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, Finan PM, Kwiatkowski DJ, Murphy LO, Manning BD. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 2012; 47:535-46.
54. Dong J, Qiu H, Garcia-Barrio M, Anderson J, Hinnebusch AG. Uncharged tRNA activates GCN2 by displacing the protein kinase moiety from a bipartite tRNA-binding domain. Mol Cell 2000;6: 269-79.
55. Kilberg MS, Shan J, Su N. ATF4-dependent transcription mediates signaling of amino acid limitation. Trends Endocrinol Metab 2009;20: 436-43.
56. Ye J, Palm W, Peng M, King B, Lindsten T, Li MO, Koumenis C, Thompson CB. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes Dev 2015; 29:2331-6.
57. Averous J, Lambert-Langlais S, Mesclon F, Carraro V, Parry L, Jousse C, Bruhat A, Maurin AC, Pierre P, Proud CG, et al. GCN2 contributes to mTORC1 inhibition by leucine deprivation through an ATF4 independent mechanism. Sci Rep 2016;6:27698.
58. Kim JS, Ro SH, Kim M, Park HW, Semple IA, Park H, Cho US, Wang Guan KL, Karin M, Lee JH. Sestrin2 inhibits mTORC1 through modulation of GATOR complexes. Sci Rep 2015;5:9502.
59. Han JM, Jeong SJ, Park MC, Kim G, Kwon NH, Kim HK, Ha SH, Ryu SH, Kim S. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 2012;149:410-24.
60. Bonfils G, Jaquenoud M, Bontron S, Ostrowicz C, Ungermann C, De Virgilio C. Leucyl-tRNA synthetase controls TORC1 via the EGO complex. Mol Cell 2012;46:105-10.
61. Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 2012;441:1-21.
62. Merrick WC. eIF4F: a retrospective. J Biol Chem 2015;290:24091-9.
63. Holz MK, Ballif BA, Gygi SP, Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 2005;123: 569-80.
64. Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J 2001;20:4370-9.
65. Suzuki C, Garces RG, Edmonds KA, Hiller S, Hyberts SG, Marintchev A, Wagner G. PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc Natl Acad Sci USA 2008; 105:3274-9.
66. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 1992;69:1227-36.
67. Richardson CJ, Bröenstrup M, Fingar DC, Jülich K, Ballif BA, Gygi S, Blenis J. SKAR is a specific target of S6 kinase 1 in cell growth control. Curr Biol 2004;14:1540-9.
68. Wilson KF, Wu WJ, Cerione RA. Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex. J Biol Chem 2000;275:37307-10.
69. Dunlop EA, Tee AR. mTOR and autophagy: a dynamic relationship governed by nutrients and energy. Semin Cell Dev Biol 2014;36: 121-9.
70. Russell RC, Yuan HX, Guan KL. Autophagy regulation by nutrient signaling. Cell Res 2014;24:42-57.
71. Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, Walther TC, Ferguson SM. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 2012;5:ra42.
72. Lamming DW, Sabatini DM. A central role for mTOR in lipid homeostasis. Cell Metab 2013;18:465-9.
73. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, Griffiths JR, Chung YL, Schulze A. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 2008;8:224-36.
74. Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 2010;39:171-83.
75. Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, Guertin DA, Madden KL, Carpenter AE, Finck BN, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011;146:408-20.
76. Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 2010;468:1100-4.
77. Kim K, Pyo S, Um SH. S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver. Hepatology 2012;55:1727-37.
78. Robitaille AM, Christen S, Shimobayashi M, Cornu M, Fava LL, Moes S, Prescianotto-Baschong C, Sauer U, Jenoe P, Hall MN. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science 2013;339:1320-3.
79. Ben-Sahra I, Howell JJ, Asara JM, Manning BD. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 2013;339:1323-8.
80. Cargnello M, Tcherkezian J, Roux PP. The expanding role of mTOR in cancer cell growth and proliferation. Mutagenesis 2015; 30:169-76.
81. Mendelsohn AR, Larrick JW. Dissecting mammalian target of rapamycin to promote longevity. Rejuvenation Res 2012;15:334-7.
82. Mackie EJ, Tatarczuch L, Mirams M. The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J Endocrinol 2011;211:109-21.
83. Baron J, Sävendahl L, De Luca F, Dauber A, Phillip M, Wit JM, Nilsson O. Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol 2015;11:735-46.
84. Phornphutkul C, Wu KY, Auyeung V, Chen Q, Gruppuso PA. mTOR signaling contributes to chondrocyte differentiation. Dev Dyn 2008; 237:702-12.
85. Chen J, Long F. mTORC1 signaling controls mammalian skeletal growth through stimulation of protein synthesis. Development 2014;141:2848-54.
86. Li C, Wang Q, Wang JF. Transforming growth factor-b (TGF-b) induces the expression of chondrogenesis-related genes through TGFb receptor II (TGFRII)-AKT-mTOR signaling in primary cultured mouse precartilaginous stem cells. Biochem Biophys Res Commun 2014;450:646-51.
87. Kim MS, Wu KY, Auyeung V, Chen Q, Gruppuso PA, Phornphutkul C. Leucine restriction inhibits chondrocyte proliferation and differentiation through mechanisms both dependent and independent of mTOR signaling. Am J Physiol Endocrinol Metab 2009;296:E1374-82.
88. Phornphutkul C, Lee M, Voigt C, Wu KY, Ehrlich MG, Gruppuso PA, Chen Q. The effect of rapamycin on bone growth in rabbits. J Orthop Res 2009;27:1157-61.
89. Chen J, Long F. mTORC1 signaling promotes osteoblast differentiation from preosteoblasts. PLoS One 2015;10:e0130627.
90. Chen J, Tu X, Esen E, Joeng KS, Lin C, Arbeit JM, Rüegg MA, Hall MN, Ma L, Long F. WNT7B promotes bone formation in part through mTORC1. PLoS Genet 2014;10:e1004145.
91. Goodman CA, Hornberger TA, Robling AG. Bone and skeletal muscle: key players in mechanotransduction and potential overlapping mechanisms. Bone 2015;80:24-36.
92. You JS, Lincoln HC, Kim CR, Frey JW, Goodman CA, Zhong XP, Hornberger TA. The role of diacylglycerol kinase z and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy. J Biol Chem 2014;289:1551-63.
93. Ham DJ, Caldow MK, Lynch GS, Koopman R. Leucine as a treatment for muscle wasting: a critical review. Clin Nutr 2014;33:937-45.
94. Sato T, Ito Y, Nagasawa T. Dietary L-lysine suppresses autophagic proteolysis and stimulates Akt/mTOR signaling in the skeletal muscle of rats fed a low-protein diet. J Agric Food Chem 2015;63:8192-8.
95. Dukes A, Davis C, El Refaey M, Upadhyay S, Mork S, Arounleut P, Johnson MH, Hill WD, Isales CM, Hamrick MW. The aromatic amino acid tryptophan stimulates skeletal muscle IGF1/p70s6k/mTor signaling in vivo and the expression of myogenic genes in vitro. Nutrition 2015;31:1018-24.
96. Manjarín R, Columbus DA, Suryawan A, Nguyen HV, Hernandez-García AD, Hoang NM, Fiorotto ML, Davis T. Leucine supplementation of a chronically restricted protein and energy diet enhances mTOR pathway activation but not muscle protein synthesis in neonatal pigs. Amino Acids 2016;48:257-67.
97. Wahl SE, McLane LE, Bercury KK, Macklin WB, Wood TL. Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination. J Neurosci 2014;34:4453-65.
98. Lebrun-Julien F, Bachmann L, Norrmén C, Trötzmüller M, Köfeler H, Rüegg MA, Hall MN, Suter U. Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination. J Neurosci 2014;34:8432-48.
99. Norrmén C, Figlia G, Lebrun-Julien F, Pereira JA, TrötzmüllerM, Köfeler HC, Rantanen V, Wessig C, van Deijk AL, Smit AB, et al. mTORC1 controls PNS myelination along the mTORC1-RXR-SREBP-lipid biosynthesis axis in Schwann cells. Cell Reports 2014;9:646-60.
100. Clevers H. The intestinal crypt, a prototype stem cell compartment. Cell 2013;154:274-84.
101. Vooijs M, Liu Z, Kopan R. Notch: architect, landscaper, and guardian of the intestine. Gastroenterology 2011;141:448-59.
102. Richmond CA, Shah MS, Deary LT, Trotier DC, Thomas H, Ambruzs DM, Jiang L, Whiles BB, Rickner HD, Montgomery RK, et al. Dormant intestinal stem cells are regulated by PTEN and nutritional status. Cell Reports 2015;13:2403-11.
103. Zhou Y, Wang Q, Weiss HL, Evers BM. Nuclear factor of activated T-cells 5 increases intestinal goblet cell differentiation through an mTOR/Notch signaling pathway. Mol Biol Cell 2014;25:2882-90.
104. Zhou Y, Rychahou P, Wang Q, Weiss HL, Evers BM. TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium. Cell Death Dis 2015;6:e1631.
105. Guan Y, Zhang L, Li X, Zhang X, Liu S, Gao N, Li L, Gao G, Wei G, Chen Z, et al. Repression of mammalian target of rapamycin complex 1 inhibits intestinal regeneration in acute inflammatory bowel disease models. J Immunol 2015;195:339-46.
106. Sampson LL, Davis AK, Grogg MW, Zheng Y. mTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice. FASEB J 2016;30:1263-75.
107. Wang H, Ji Y, Wu G, Sun K, Sun Y, Li W, Wang B, He B, Zhang Q, Dai Z, et al. L-tryptophan activates mammalian target of rapamycin and enhances expression of tight junction proteins in intestinal porcine epithelial cells. J Nutr 2015;145:1156-62.
108. Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, Zheng P. TSCmTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 2008;205:2397-408.
109. Kalaitzidis D, Sykes SM, Wang Z, Punt N, Tang Y, Ragu C, Sinha AU, Lane SW, Souza AL, Clish CB, et al. mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis. Cell Stem Cell 2012;11:429-39.
110. Knight ZA, Schmidt SF, Birsoy K, Tan K, Friedman JM. A critical role for mTORC1 in erythropoiesis and anemia. eLife 2014;3:e01913.
111. Chung J, Bauer DE, Ghamari A, Nizzi CP, Deck KM, Kingsley PD, Yien YY, Huston NC, Chen C, Schultz IJ, et al. The mTORC1/4EBP pathway coordinates hemoglobin production with L-leucine availability. Sci Signal 2015;8:ra34.
112. Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr 2008;28:197-213.
113. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 2012;1823:1434-43.
114. Bayeva M, Khechaduri A, Puig S, Chang HC, Patial S, Blackshear PJ, Ardehali H. mTOR regulates cellular iron homeostasis through tristetraprolin. Cell Metab 2012;16:645-57.
115. Guan P, Wang N. Mammalian target of rapamycin coordinates iron metabolism with iron-sulfur cluster assembly enzyme and tristetraprolin. Nutrition 2014;30:968-74.
116. Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, Xiao B, Worley PF, Powell JD. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 2011;12:295-303.
117. Pollizzi KN, Patel CH, Sun IH, Oh MH, Waickman AT, Wen J, Delgoffe GM, Powell JD. mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation. J Clin Invest 2015;125:2090-108.
118. Marçais A, Cherfils-Vicini J, Viant C, Degouve S, Viel S, Fenis A, Rabilloud J, Mayol K, Tavares A, Bienvenu J, et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol 2014;15: 749-57.
119. Lee K, Heffington L, Jellusova J, Nam KT, Raybuck A, Cho SH, Thomas JW, Rickert RC, Boothby M. Requirement for Rictor in homeostasis and function of mature B lymphoid cells. Blood 2013;122: 2369-79.
120. Zhang Y, Hu T, Hua C, Gu J, Zhang L, Hao S, Liang H, Wang X, Wang W, Xu J, et al. Rictor is required for early B cell development in bone marrow. PLoS One 2014;9:e103970.
121. Keating R, Hertz T, Wehenkel M, Harris TL, Edwards BA, McClaren JL, Brown SA, Surman S, Wilson ZS, Bradley P, et al. The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus. Nat Immunol 2013;14:1266-76.
122. Lui JC, Garrison P, Baron J. Regulation of body growth. Curr Opin Pediatr 2015;27:502-10.
123. Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev 2016;30:1-17.
124. Hansen CG, Ng YL, Lam WL, Plouffe SW, Guan KL. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Cell Res 2015;25:1299-313.
125. RoseWC, Oesterling MJ, Womack M. Comparative growth on diets containing ten and nineteen amino acids, with further observations upon the role of glutamic and aspartic acids. J Biol Chem 1948;176:753-62.
126. Irwin MI, Hegsted DM. A conspectus of research on amino acid requirements of man. J Nutr 1971;101:539-66.
127. Sanfilippo S, Imbesi RM, Sanfilippo S Jr. Effects of a tryptophan deficient diet on the morphology of skeletal muscle fibers of the rat: preliminary observations at neuroendocrinological and submicroscopical levels. Ital J Anat Embryol 1995;100(Suppl 1):131-41.
128. Imbesi R, Mazzone V, Castrogiovanni P. Is tryptophan 'more' essential than other essential amino acids in development? A morphologic study. Anat Histol Embryol 2009;38:361-9.
129. González EM, Penedo LA, Oliveira-Silva P, Campello-Costa P, Guedes RC, Serfaty CA. Neonatal tryptophan dietary restriction alters development of retinotectal projections in rats. Exp Neurol 2008;211:441-8.
130. Penedo LA, Oliveira-Silva P, Gonzalez EM, Maciel R, Jurgilas PB, Melibeu Ada C, Campello-Costa P, Serfaty CA. Nutritional tryptophan restriction impairs plasticity of retinotectal axons during the critical period. Exp Neurol 2009;217:108-15.
131. Zhang L, Guadarrama L, Corona-Morales AA, Vega-Gonzalez A, Rocha L, Escobar A. Rats subjected to extended L-tryptophan restriction during early postnatal stage exhibit anxious-depressive features and structural changes. J Neuropathol Exp Neurol 2006;65:562-70.
132. Zhang L, Corona-Morales AA, Vega-González A, García-Estrada J, Escobar A. Dietary tryptophan restriction in rats triggers astrocyte cytoskeletal hypertrophy in hippocampus and amygdala. Neurosci Lett 2009;450:242-5.
133. Anthony TG, McDaniel BJ, Byerley RL, McGrath BC, Cavener DR, McNurlan MA, Wek RC. Preservation of liver protein synthesis during dietary leucine deprivation occurs at the expense of skeletal muscle mass in mice deleted for eIF2 kinase GCN2. J Biol Chem 2004;279: 36553-61.
134. Guo F, Cavener DR. The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab 2007;5:103-14.
135. Cheng Y, Meng Q, Wang C, Li H, Huang Z, Chen S, Xiao F, Guo F. Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (UCP1) in brown adipose tissue. Diabetes 2010;59:17-25.
136. Xiao F, Huang Z, Li H, Yu J, Wang C, Chen S, Meng Q, Cheng Y, Gao X, Li J, et al. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes 2011;60:746-56.
137. Xiao F, Yu J, Guo Y, Deng J, Li K, Du Y, Chen S, Zhu J, Sheng H, Guo F. Effects of individual branched-chain amino acids deprivation on insulin sensitivity and glucosemetabolism in mice. Metabolism 2014;63:841-50.
138. Du Y, Meng Q, Zhang Q, Guo F. Isoleucine or valine deprivation stimulates fat loss via increasing energy expenditure and regulating lipid metabolism in WAT. Amino Acids 2012;43:725-34.
139. Tamaki N, Tsunemori F, Wakabayashi M, Hama T. Effect of histidinefree and-excess diets on anserine and carnosine contents in rat gastrocnemius muscle. J Nutr Sci Vitaminol (Tokyo) 1977;23:331-40.
140. Clemens RA, Kopple JD, Swendseid ME. Metabolic effects of histidine-deficient diets fed to growing rats by gastric tube. J Nutr 1984; 114:2138-46.
141. Parker CJ Jr., Riess GT, Sardesai VM. Essentiality of histidine in adult mice. J Nutr 1985;115:824-6.
142. Faure M, Moënnoz D, Montigon F, Mettraux C, Breuillé D, Ballèvre O. Dietary threonine restriction specifically reduces intestinal mucin synthesis in rats. J Nutr 2005;135:486-91.
143. Law GK, Bertolo RF, Adjiri-Awere A, Pencharz PB, Ball RO. Adequate oral threonine is critical for mucin production and gut function in neonatal piglets. Am J Physiol Gastrointest Liver Physiol 2007;292:G1293-301.
144. Hamard A, Sève B, Le Floc'h N. Intestinal development and growth performance of early-weaned piglets fed a low-threonine diet. Animal 2007;1:1134-42.
145. Hamard A, Sève B, Le Floc'h N. A moderate threonine deficiency differently affects protein metabolism in tissues of early-weaned piglets. Comp Biochem Physiol A Mol Integr Physiol 2009;152:491-7.
146. Hamard A, Mazurais D, Boudry G, Le Huërou-Luron I, Sève B, Le Floc'h N. A moderate threonine deficiency affects gene expression profile, paracellular permeability and glucose absorption capacity in the ileum of piglets. J Nutr Biochem 2010;21:914-21.
147. Wang X, Qiao S, Yin Y, Yue L, Wang Z, Wu G. A deficiency or excess of dietary threonine reduces protein synthesis in jejunum and skeletal muscle of young pigs. J Nutr 2007;137:1442-6.
148. Yang YX, Guo J, Jin Z, Yoon SY, Choi JY, Wang MH, Piao XS, Kim BW, Chae BJ. Lysine restriction and realimentation affected growth, blood profiles and expression of genes related to protein and fat metabolism in weaned pigs. J Anim Physiol Anim Nutr (Berl) 2009;93:732-43.
149. Ishida A, Kyoya T, Nakashima K, Katsumata M. Muscle protein metabolism during compensatory growth with changing dietary lysine levels from deficient to sufficient in growing rats. J Nutr Sci Vitaminol (Tokyo) 2011;57:401-8.
150. Kobayashi H, Ishida A, Ashihara A, Nakashima K, Katsumata M. Effects of dietary low level of threonine and lysine on the accumulation of intramuscular fat in porcine muscle. Biosci Biotechnol Biochem 2012;76:2347-50.
151. Kim J, Lee KS, Kwon DH, Bong JJ, Jeong JY, Nam YS, Lee MS, Liu X, Baik M. Severe dietary lysine restriction affects growth and body composition and hepatic gene expression for nitrogen metabolism in growing rats. J Anim Physiol Anim Nutr (Berl) 2014;98:149-57.
152. Anthony TG, Reiter AK, Anthony JC, Kimball SR, Jefferson LS. Deficiency of dietary EAA preferentially inhibits mRNA translation of ribosomal proteins in liver of meal-fed rats. Am J Physiol Endocrinol Metab 2001;281:E430-9.
153. WHO/FAO/United Nations University. Protein and amino acid requirements in human nutrition. Report of a Joint WHO/FAO/UNU Expert Consultation. World Health Organ Tech Rep Ser 2007;1-265.
154. Pillai RR, Kurpad AV. Amino acid requirements in children and the elderly population. Br J Nutr 2012;108(Suppl 2):S44-9.
155. Reeds PJ, Garlick PJ. Protein and amino acid requirements and the composition of complementary foods. J Nutr 2003;133:2953S-61S.
156. Uauy R. Rethinking protein. Food Nutr Bull 2013;34:228-31.
157. Pillai RR, Elango R, Ball RO, Kurpad AV, Pencharz PB. Lysine requirements of moderately undernourished school-aged Indian children are reduced by treatment for intestinal parasites as measured by the indicator amino acid oxidation technique. J Nutr 2015;145:954-9.
158. Millward DJ, Jackson AA. Protein requirements and the indicator amino acid oxidation method. Am J Clin Nutr 2012;95:1498-501.
159. Elango R, Ball RO, Pencharz PB. Indicator amino acid oxidation: concept and application. J Nutr 2008;138:243-6.
160. Rand WM, Pellett PL, Young VR. Meta-analysis of nitrogen balance studies for estimating protein requirements in healthy adults. Am J Clin Nutr 2003;77:109-27.
161. Delgoffe GM, Powell JD. Feeding an army: the metabolism of T cells in activation, anergy, and exhaustion. Mol Immunol 2015;68(2 Pt C): 492-6.
162. Kampman-van de Hoek E, Jansman AJ, van den Borne JJ, van der Peet-Schwering CM, van Beers-Schreurs H, Gerrits WJ. Dietary amino acid deficiency reduces the utilization of amino acids for growth in growing pigs after a period of poor health. J Nutr 2016;146:51-8.
163. Tomé D, Jahoor F, Kurpad A, Michaelsen KF, Pencharz P, Slater C, Weisell R. Current issues in determining dietary protein quality and metabolic utilization. Eur J Clin Nutr 2014;68:537-8.
164. Schaafsma G. The protein digestibility-corrected amino acid score. J Nutr 2000;130:1865S-7S.
165. Food and Agriculture Organization. Dietary protein quality evaluation in human nutrition: report of an FAO Expert Consultation. Rome (Italy): FAO; 2013. FAO Food and Nutrition Paper No.: 92.
166. Dror DK, Allen LH. The importance of milk and other animal-source foods for children in low-income countries. Food Nutr Bull 2011;32: 227-43.
167. Krebs NF, Mazariegos M, Tshefu A, Bose C, Sami N, Chomba E, Carlo W, Goco N, Kindem M, Wright LL, et al; Complementary Feeding Study Group. Meat consumption is associated with less stunting among toddlers in four diverse low-income settings. Food Nutr Bull 2011;32:185-91.
168. Schönbeck Y, Talma H, van Dommelen P, Bakker B, Buitendijk SE, HiraSing RA, van Buuren S. The world's tallest nation has stopped growing taller: the height of Dutch children from 1955 to 2009. Pediatr Res 2013;73:371-7.
169. Stulp G, Barrett L, Tropf FC, Mills M. Does natural selection favour taller stature among the tallest people on earth? Proc Biol Sci 2015; 282:20150211.
170. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 2000;47:316-23.
171. de Beer H. Dairy products and physical stature: a systematic review and meta-analysis of controlled trials. Econ Hum Biol 2012;10:299-309.
172. Semba RD, Shardell M, Trehan I, Moaddel R, Maleta KM, Ordiz MI, Kraemer K, Khadeer M, Ferrucci L, Manary MJ. Metabolic alterations in children with environmental enteric dysfunction. Sci Rep 2016;6: 28009.
173. Layman DK, Anthony TG, Rasmussen BB, Adams SH, Lynch CJ, Brinkworth GD, Davis TA. Defining meal requirements for protein to optimize metabolic roles of amino acids. Am J Clin Nutr 2015; 101:1330S-1338S.